000153SZSE

Announcement of Shareholders' Meeting Resolutions for 2025

Fengyuan Pharmaceutical Co., Ltd.··4 pages

Exchange Summary

AGM RESOLUTION

The Company held its Annual General Meeting of 2025 on 26 May 2026, during which the following proposal(s) was/were approved: 1. 2025 annual report and its summary 2. 2025 work report of the board of directors 3. 2025 profit distribution plan 4. Reappointment of audit firm and the audit fees 5. 2026 application for comprehensive credit line to banks 6. Remuneration management system for directors and senior management 7. 2026 remuneration plan for directors The detailed profit distribution plan is as follows: 1) Cash dividend/10 shares (tax included): CNY1.00000000 2) Bonus issue from profit (share/10 shares): none 3) Bonus issue from capital reserve (share/10 shares): none

Provided by Shenzhen Stock Exchange

Full Translation